Follow the IXICO plc share price and the full directors' dealings record of the company, a publicly traded company based in United Kingdom. Shares are quoted on the UK market, under the oversight of RNS (LSE). Market capitalisation: €16.4m. The latest transaction was disclosed on 16 July 2026 (Purchase). Among the most active insiders: Mark Warne. Every trade is free.
7
Insider Decl.
n/a
Thresholds
€105,707
7 ops.
Buy Volume
n/a
n/a
Sell Volume
30Σ signal
Buys €105,707n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 25,693 of 28,802 companies
22.7
score / 100
Value
15
Quality
30
FCF yld-11%
Earn yld-10%
EV/EBITDA·
ROE-16%
Gross mgn49%
Net mgn-25%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
44,000 shares@ £0.1203100.0% of flowFrankfurt (Germany)RNS:5390671
7 of 7 declarations
About IXICO plc
IXICO plc is a company specializing in data analytics for the healthcare sector, particularly in clinical trials. It provides solutions to enhance decision-making in drug development.